Global Alopecia Drugs Market By Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), By Application (Hospitals And Clinics, Salons, Home Care), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast to 2027
- Published date: Apr 2022
- Report ID: 23412
- Number of Pages: 287
- Format:
- keyboard_arrow_up
1.0 Chapter 1
- 1.1 Preface
- 1.2 Assumptions
- 1.3 Abbreviations
2.0 Chapter 2
- 2.1 Report Description
- 2.1.1 Market Definition and Scope
- 2.2 Executive Summary
- 2.2.1 Market Snapshot, By Route of Administration
- 2.2.2 Market Snapshot, By Gender
- 2.2.3 Market Snapshot, By Geography
3.0 Chapter 3
- 3.1 Global Alopecia Drugs Market Dynamics
- 3.1.1 Drivers
- 3.1.2 Restraints
- 3.1.3 Opportunities
- 3.1.4 PEST Analysis
- 3.1.5 PORTERS Analysis
4.0 Chapter 4
- 4.0.1 Global Alopecia Drugs Market Analysis, by Route of Administration
- 4.0.2 Overview
- 4.0.3 Segment Trends
- 4.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
- 4.1 Oral
- 4.1.1 Overview
- 4.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
- 4.2 Injectable
- 4.2.1 Overview
- 4.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
- 4.3 Topical
- 4.3.1 Overview
- 4.3.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
5.0 Chapter 5
- 5.0.1 Global Alopecia Drugs Market Analysis, by Gender
- 5.0.2 Overview
- 5.0.3 Segment Trends
- 5.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
- 5.1 Men
- 5.1.1 Overview
- 5.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
- 5.2 Women
- 5.2.1 Overview
- 5.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
6.0 Chapter 6
- 6.0.1 Global Alopecia Drugs Market Analysis, by Region
- 6.0.2 Overview
- 6.0.3 Regional Trends
- 6.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
- 6.1 The Americas
- 6.1.1 Overview
- 6.1.2 Country Trends
- 6.1.3 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
- 6.1.4 U.S.
- 6.1.5 Canada
- 6.1.6 Rest of America
- 6.2 Europe
- 6.2.1 Overview
- 6.2.2 Country Trends
- 6.2.3 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
- 6.2.4 Germany
- 6.2.5 France
- 6.2.6 Spain
- 6.2.7 U.K.
- 6.2.8 Rest of Europe
- 6.3 Asia Pacific
- 6.3.1 Overview
- 6.3.2 Country Trends
- 6.3.3 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
- 6.3.4 China
- 6.3.5 India
- 6.3.6 Japan
- 6.3.7 Australia
- 6.3.8 Rest of APAC
- 6.4 Rest of the World
- 6.4.1 Overview
- 6.4.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
7.0 Chapter 7
- 7.0.1 Competitive Dashboard
- 7.0.2 Heat Map Analysis
- 7.0.3 Company Profiles
- 7.1 Taisho Pharmaceutical Holdings Co. Ltd.*
- 7.1.1 Company Overview
- 7.1.2 Product Portfolio
- 7.1.3 Financial Overview
- 7.1.4 Key Developments
- 7.1.5 SWOT Analysis
- 7.2 The Himalaya Drug company
- 7.3 Johnson & Johnson Services, Inc.
- 7.4 GlaxoSmithKline Plc.
- 7.5 Cipla Inc.
- 7.6 Dr. Reddy’s Laboratories Ltd.
- 7.7 MERCK
- 7.8 Vitabiotic Ltd.
- 7.9 Sun Pharmaceutical Industries Ltd.
8.0 Chapter 8
- 8.1 About Us
- 8.2 Research Methodology
- Taisho Pharmaceutical Holdings Co. Ltd.
- The Himalaya Drug Company
- Johnson & Johnson Services, Inc.
- GlaxoSmithKline Plc.
- Cipla Inc.
- Dr. Reddys Laboratories Ltd Company Profile
- Merck KGaA Company Profile
- Vitabiotics Ltd.
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |